Rob Woolstencroft
Head of Market Access at Alexion Pharmaceuticals, Inc. | Oakville, Ontario, Canada
Rob Woolstencroft’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Head of Market Access at Alexion Pharmaceuticals, Inc. in October 2024 - Present
Head, Market Access and Reimbursement at Gilead Sciences in January 2022 - October 2024
Director, Patient Access and Government Affairs at EMD Serono, Inc. in May 2018 - January 2022
Director, Market Access (Canada) at Vertex Pharmaceuticals in August 2016 - January 2018
Director, CF Global Marketing at Vertex Pharmaceuticals in September 2014 - August 2016
Head, Marketing and Sales - Canada at Vertex Pharmaceuticals in July 2011 - September 2014
Director, Hepatitis and Fertility Franchises - Canada at Merck in March 2010 - July 2011
Acting Director, Fertility Business Unit and Scientific Director, Virology at Merck in May 2009 - February 2010
Scientific Director, Canada at Merck in October 2007 - April 2009
Medical Scientific Specialist at Merck in December 2006 - October 2007
University of Toronto, Ph.D., July 2026
University of Toronto - Rotman School of Management, Bridge to Business Executive Program, July 2026
McMaster University, M.Sc., July 1998 to July 2026
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease. A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
Discover more about Alexion Pharmaceuticals, Inc.
Strategic Corporate Communications and Public Relations Leader | Crisis & Issues Management | Change & Transformation | ESG | Certified Chief of Staff
Founder and Principal at SDB Communications
(February 2024 – Present)
Patient Centric Marketer | AstraZeneca Rare Disease
Associate Director, US Patient Marketing, Neurology, gMG at Alexion Pharmaceuticals, Inc.
(July 2024 – Present)
Nonclinical Drug Safety and Toxicology/Drug Development/Regulatory Filings/Global and Cross-Functional Teams/Building Confidence in Safety
Senior Director, Nonclinical Toxicology at Alexion Pharmaceuticals, Inc.
(April 2023 – Present)
Consultora de Doenças Raras
Consultora Técnica - COVID-19 - Vaccines & Immune Therapies at AstraZeneca
(February 2022 – Present)
Global Marketing Event Management | Innovation and Continual Process Improvement | Medical Congress Strategy and Engagement | Biotech Virtual & Hybrid Events
Associate Director, Event Strategy and Operations, Congress Lead at Alexion Pharmaceuticals, Inc.
(January 2022 – Present)
Líder de Contas|Gerente de contas|Doenças Raras|key account Manager|Consultor Técnico|KAM|Acesso
Scientific Consultant, Rare Diseases - Alexion, AstraZeneca at Alexion Pharmaceuticals, Inc.
(January 2024 – Present)
What is Rob Woolstencroft email address?
Email Rob Woolstencroft at [email protected] and [email protected]. This email is the most updated Rob Woolstencroft's email found in 2026.
How to contact Rob Woolstencroft?
To contact Rob Woolstencroft send an email to [email protected] or [email protected]. (updated on October 14, 2025)
What company does Rob Woolstencroft work for?
Rob Woolstencroft works for Alexion Pharmaceuticals, Inc..
What is Rob Woolstencroft's role at Alexion Pharmaceuticals, Inc.?
Rob Woolstencroft is Head of Market Access
What industry does Rob Woolstencroft work in?
Rob Woolstencroft works in the Biotechnology industry.
